Metabolic Syndrome and Combination Antiretroviral Therapy in HIV Patients in Periurban Hospital in Ghana: A Case-Control Study
Table 3
Association between metabolic syndrome and its components among study participants.
ART-naïve HIV patients, OR (95% CI)
cART-treated HIV patients, OR (95% CI)
Unadjusted
Adjusted
Unadjusted
Adjusted
IFG
1.06 (0.67–1.7)
0.85 (0.49–1.48)
3.26 (2.05–5.17)
2.19 (1.19–4.03)
High systolic BP
1.03 (0.66–1.62)
0.96 (0.55–1.69)
1.08 (0.69–1.68)
0.56 (0.29–1.07)
Abdominal obesity
0.64 (0.41–1.01)
0.52 (0.29–0.97)
1.88 (1.18–3)
0.8 (0.39–1.65)
Low HDL
1.21 (0.72–2.04)
2.17 (1.14–4.12)
2.15 (1.32–3.52)
6.22 (2.91–13.32)
Hypertriglyceridemia
1.14 (0.65–2.03)
1.07 (0.53–2.16)
4.93 (2.95–8.25)
4.72 (2.23–9.96)
MetS
1.4 (0.83–2.35)
1.3 (0.69–2.46)
6.54 (3.96–10.78)
4.62 (2.35–9.07)
The model for adjusted OR were adjusted for age, gender, marital status, alcohol and smoking status, employment, educational level, and BMI. IFG, impaired fasting plasma glucose; BP, blood pressure; HDL, high density lipoprotein cholesterol; MetS, metabolic syndrome.
